NATROX^® Wound Care: Empowering Patients, Transforming Lives and Redefining Global Healthcare Standards with NATROX^® O₂ Continuous Topical Oxygen Therapy

The Silicon Review

In the ever-evolving landscape of healthcare, advancements in wound care technology are crucial for improving patient outcomes and quality of life. Among the pioneers in this field is NATROX Wound Care (NATROX) (natroxwoundcare.com), a brand dedicated to introducing leading-edge solutions to healthcare practitioners worldwide with a goal to heal as many patients as possible. Based in Cambridge, England, NATROX, stands as a progressive force in the specialized field of wound care. With a focused commitment to introducing state-of-the-art technologies, the company’s primary objective revolves around enhancing the healing process for patients grappling with chronic wounds. At the forefront of their offerings is the innovative medtech device, NATROX O₂, poised to become an indispensable component of wound care protocols across the globe in the foreseeable future.

In an exclusive interview with The Silicon Review, Craig Kennedy, the CEO of NATROX, discussed how he and his team are pioneering advancements in the treatment of chronic wounds while fostering renewed vitality and well-being among patients.

The Genesis of NATROX Wound Care

NATROX stands as the vanguard of advanced wound care therapies, born from a deeply personal mission to enhance the lives of those battling non-healing wounds.

Founded in 2005 by Alan Hurst, Mel Vinton, and Prof Derek Fray, NATROX O₂ is NATROX’s flagship product and the brainchild of innovative minds at Cambridge University. Originating as a concept conceived within the university’s halls, NATROX O₂ transitioned from academia to commercialization, driven by the unwavering commitment to revolutionize wound care and expedite the healing process for patients with chronic wounds.

Today, NATROX maintains its dedication to enhancing user experience and accessibility through ongoing product development initiatives. Evolving alongside the ever-changing needs of the medical community, the company offers an expanded product portfolio that includes advanced wound care technology (NATROX^® O₂), digital data solutions (NATROX^® IQ) and comprehensive support programs (NATROX^® Wound Solutions) to benefit both healthcare providers and patients.

Through strategic partnerships with healthcare organizations like the NHS and US Veterans Affairs (VA), as well as robust distributor networks spanning across countries, NATROX ensures widespread availability and coverage for its groundbreaking products. With each passing year, the company expands its reach, adding new partners and widening its base to cater to the growing needs of patients worldwide.

NATROX Wound Care’s Key Focus Areas

As a specialist wound care company, NATROX is driven by a steadfast commitment to revolutionary breakthroughs that transform the lives of patients suffering from non-healing wounds. At the core of its mission is NATROX O2, a discreet wearable device designed to harness the natural healing properties of oxygen.

“Amidst a landscape saturated with stagnant innovation, NATROX Wound Care stands as a beacon of change,” affirms Craig Kennedy. Its avant-garde methodology not only offers trailblazing therapeutic solutions but also places paramount importance on patient quality of life throughout every phase of treatment.

Kennedy further highlights NATROX’s proactive initiatives, particularly within the US market, “As we inch closer to gaining reimbursement for a broader population base, we’re ramping up efforts to raise public awareness.” Notably, strides have been made within the VA and New York State Medicaid, setting the stage for expansive accessibility of NATROX’s innovative solutions.

With a mission firmly rooted in patient-centric care, NATROX is committed to delivering transformative wound care technology that seamlessly integrates across the care continuum. “Everything we do begins and ends with the patient.” This dedication is evident in its innovative digital platform, (NATROX^® IQ), which provides healthcare professionals with intuitive tools to efficiently manage their wound caseloads across multiple care settings.

In their unwavering pursuit of excellence, NATROX continues to push the boundaries of wound care treatment, even in the most challenging cases of chronic, non-healing wounds. With each advancement, they reaffirm their commitment to transforming patients’ lives and revolutionizing the future of wound care.

NATROX O₂: Revolutionizing Wound Care on a Global Scale

Oxygen plays a crucial role in every stage of wound healing. However, patients with chronic or hard-to-heal wounds often face challenges in delivering oxygen to the affected tissue, leading to stalled healing processes. For these patients, supplemental oxygen can help. NATROX O₂ addresses this issue by providing oxygen directly to the wound site, overcoming barriers to healing and promoting tissue regeneration.

“We have seen the evidence for Continuous Topical Oxygen Therapy reach new global scale and experts are recognizing its ability to transform wound care,” emphasizes Mr. Kennedy.

Guided by a commitment to improve patient outcomes, NATROX O₂ offers a non-invasive, user-friendly therapy designed to accelerate healing, even in wounds that have persisted for years, such as diabetic foot ulcers, venous leg ulcers, pressure injuries, and non-healing surgical or traumatic wounds.

“NATROX O₂ is ready to make a global impact following six years of meticulous preparation,” shares Kennedy. This significant milestone underscores the company’s dedication to providing advanced wound care solutions to patients worldwide.

Product Description

NATROX O₂ is a wearable medical device engineered to continuously deliver topical oxygen directly to the wound, enhancing the healing process. Portable, discreet, and completely silent, this battery-powered device allows patients to seamlessly integrate therapy into their daily lives while experiencing the benefits of accelerated healing. By delivering vital oxygen properties to chronic, non-healing wounds, NATROX O₂ serves as an adjunct to the standard of care, offering a novel approach to wound management.

Mode of Action

Through a process of water electrolysis, the NATROX O₂ Oxygen Generator (OG) produces a flow of highly concentrated oxygen, which is then delivered to the wound using the NATROX O₂ Oxygen Delivery System (ODS). The sterile, single-use ODS features a soft, pliable “wheel” shape, ensuring optimal oxygen flow while maintaining patient comfort. Powered by rechargeable batteries, the OG operates continuously, ensuring the optimal oxygenation of affected tissue and creating an ideal healing environment while maintaining ease of use for the patients.

Empowering Patients with Continuous Topical Oxygen Therapy (cTOT)

In addition to providing an effective therapy that allows mobility during treatment, NATROX O₂ has proven beneficial in many aspects of wound management. Pain, for example, is a significant challenge for patients dealing with chronic wounds, impacting their quality of life and overall well-being. NATROX O₂ has demonstrated promising results in alleviating pain, leading to improved healing outcomes and enhancing patients’ quality of life.

Discover the transformative power of NATROX O₂ in wound care through firsthand accounts from clinicians, patients, and caregivers. “Healing Journeys Unveiled” delves into the experiences of those who have witnessed the remarkable benefits of NATROX O₂ in managing chronic wounds. These compelling narratives provide insight into how NATROX O₂ is revolutionizing wound care, providing hope and relief to individuals navigating the challenges of chronic wounds.

NATROX IQ: Transforming Wound Care Management

In an era where technological advancements are transforming healthcare management, NATROX IQ stands out as a game-changer for wound care providers. While patients can experience advanced therapy at home using NATROX O₂, NATROX IQ serves as a powerful tool for clinicians overseeing the patients’ care. Its centralized, cloud-based platform simplifies caseload management, and is particularly beneficial for multidisciplinary teams. By providing actionable insights and personalized care strategies, NATROX IQ empowers clinical teams to deliver optimal care, transcending geographical barriers and enhancing patient outcomes.

The digital platform of NATROX IQ offers an advanced hub where clinical teams—across various locations and disciplines—can capture and access up-to-date information on wound care patients. The platform integrates with third-party software that captures images and digitally measures wound size and depth, providing accurate and consistent data to monitor the healing progression.

“NATROX IQ represents a paradigm shift in remote wound care management. Our goal is to provide clinicians with access to advanced technology that enhances communication with their patients and ultimately improves treatment outcomes,” says the CEO.

NATROX IQ also features a telemedicine capability that enables active communication remotely between patients and clinicians, reducing the need for in-clinic appointments while facilitating ongoing dialogue among all care team members.

Through intuitive features such as wound imaging, standardized measurements, and progress-related assessments, NATROX IQ empowers clinicians to supervise patients remotely and provide tailored guidance based on individual responses.

Operational Efficiency and Improved Patient Outcomes

A collaborative study ¹revealed significant advantages of the NATROX IQ program, particularly when combined with NATROX O₂ Continuous Topical Oxygen Therapy. Patients reported enhanced communication with their clinicians, leading to greater engagement and adherence to treatment plans.

The implementation of NATROX IQ yielded remarkable results ¹, with a 54.0% increase in operational efficiencies and a 25.8% reduction in clinical time. Health status scores improved across all patients, reflecting the tangible impact of remote wound care management. Feedback on the shared approach with NATROX O₂ was overwhelmingly positive, highlighting the value of innovative solutions in enhancing patient access, engagement and overall well-being.

NATROX IQ represents a significant step forward in NATROX’s commitment to providing advanced solutions for clinicians and better care for patients. Explore the features and benefits of NATROX IQ.

Client Testimonial

Bonnie Horsfall’s Journey with NATROX O₂

Discovery of the Wound: In February 2020, Bonnie Horsfall noticed a troubling leg wound while awaiting a kidney donation. The wound persisted for over a month, leading to a diagnosis of calciphylaxis, hospitalizing her for five days and removing her from the transplant list.

The Quest for Treatment: Determined to find a solution during the Covid-19 shelter-in-place order, Bonnie’s wound care physician prescribed a wearable, continuous topical oxygen therapy that could be managed at home.

Embracing Continuous Topical Oxygen Therapy (cTOT): Despite being unfamiliar with topical oxygen as a treatment option for chronic wounds, Bonnie embraced cTOT with NATROX O₂. She experienced significant improvement within weeks, reducing pain and restoring hope.

Transformation and Gratitude: Over the next three months, NATROX O₂ played a vital role in healing Bonnie’s wound, enabling her to resume the transplant journey that ultimately let her to receiving a new kidney. Grateful for its effectiveness and convenience, Bonnie credits NATROX O₂ with saving her life and restoring her vitality.

Feedback: “I would highly recommend NATROX O₂ to others because of its ease of use, convenience and effectiveness. It doesn’t interfere with anything and is very, very effective. The treatment saved my life in more ways than one, and I am incredibly thankful for it.”

Road Ahead

NATROX remains resolute in its mission to transform lives by empowering patients and supporting clinicians. With NATROX O₂’s regulatory approvals in over 25 countries, NATROX is expanding access globally to innovative wound care solutions. Its third product offering, NATROX Wound Solutions, which is piloting in Asia, redefines diagnostic and treatment standards backed by unparalleled education and clinical support.

“Our continued focus on studies and product development aims to broaden the therapeutic benefits of cTOT, offering a broader range of treatment options to meet the diverse needs of patients worldwide,” concludes Craig Kennedy.

¹Lee A, et al. Remote assessment and monitoring with advanced wound therapy to optimise clinical outcomes, access and resources. J Wound Care. 2024 Feb 2;33(2):90-101.